12:10 AM EST, 11/04/2026 (MT Newswires) -- Theraclion (ALTHE.PA) bagged the medical device marketing authorization for its therapeutic ultrasound platform, Sonovein, from the Saudi Food and Drug Authority. The approval allows the French medical technology company to market its non-invasive treatment of varicose veins in Saudi Arabia, according to a Tuesday release.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.